Company profile CPRX

Catalyst Pharmaceuticals Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 19:18:14.

After 39 days of this quarter the interest is at 33.0. Based on that we can calculate that during remaining 52 days it will total up to 77.0.
Catalyst Pharmaceuticals expected interest is significantly lower compared to same quarter last year (-40.3%) but similar to previous quarter.

YearQ1Q2Q3Q4
2019122
150
23.0% QoQ
118
-21.3% QoQ
133
12.7% QoQ
2020 303
148.4% YoY 127.8% QoQ
261
74.0% YoY -13.9% QoQ
259
119.5% YoY -0.8% QoQ
189
42.1% YoY -27.0% QoQ
2021 400
32.0% YoY 111.6% QoQ
243
-6.9% YoY -39.2% QoQ
75
-71.0% YoY -69.1% QoQ
83
-56.1% YoY 10.7% QoQ
2022 76
-81.0% YoY -8.4% QoQ
34
-86.0% YoY -55.3% QoQ
104
38.7% YoY 205.9% QoQ
86
3.6% YoY -17.3% QoQ
2023 129
69.7% YoY 50.0% QoQ
87
155.9% YoY -32.6% QoQ
73
-29.8% YoY -16.1% QoQ
93
8.1% YoY 27.4% QoQ
2024 33
-74.4% YoY -64.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Catalyst Pharmaceuticals search interestLast update: February 08 2024 19:18:14.
Correlation coefficient between keyword and revenue is -0.4
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 19:18:15.

The average 5 years interest of Catalyst Pharmaceuticals was 11.69 per week.
The last year interest of Catalyst Pharmaceuticals compared to the last 5 years has changed by -44.91%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -43.9%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 19:18:20.

After 39 days of this quarter the interest is at 117.0. Based on that we can calculate that during remaining 52 days it will total up to 273.0.
Firdapse expected interest is significantly higher compared to previous quarter (+206.7%) and same quarter last year (+131.4%).

YearQ1Q2Q3Q4
2019316
228
-27.8% QoQ
98
-57.0% QoQ
39
-60.2% QoQ
2020 58
-81.6% YoY 48.7% QoQ
42
-81.6% YoY -27.6% QoQ
79
-19.4% YoY 88.1% QoQ
110
182.1% YoY 39.2% QoQ
2021 72
24.1% YoY -34.5% QoQ
36
-14.3% YoY -50.0% QoQ
115
45.6% YoY 219.4% QoQ
98
-10.9% YoY -14.8% QoQ
2022 90
25.0% YoY -8.2% QoQ
117
225.0% YoY 30.0% QoQ
118
2.6% YoY 0.9% QoQ
60
-38.8% YoY -49.2% QoQ
2023 118
31.1% YoY 96.7% QoQ
29
-75.2% YoY -75.4% QoQ
83
-29.7% YoY 186.2% QoQ
89
48.3% YoY 7.2% QoQ
2024 117
-0.8% YoY 31.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Firdapse search interestLast update: February 08 2024 19:18:20.
Correlation coefficient between keyword and revenue is -0.34
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 19:18:22.

The average 5 years interest of Firdapse was 8.09 per week.
The last year interest of Firdapse compared to the last 5 years has changed by -12.73%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -48.8%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 19:18:29.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Ruzurgi expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
201958
202
248.3% QoQ
124
-38.6% QoQ
118
-4.8% QoQ
2020 62
6.9% YoY -47.5% QoQ
53
-73.8% YoY -14.5% QoQ
94
-24.2% YoY 77.4% QoQ
136
15.3% YoY 44.7% QoQ
2021 68
9.7% YoY -50.0% QoQ
237
347.2% YoY 248.5% QoQ
179
90.4% YoY -24.5% QoQ
119
-12.5% YoY -33.5% QoQ
2022 72
5.9% YoY -39.5% QoQ
134
-43.5% YoY 86.1% QoQ
87
-51.4% YoY -35.1% QoQ
36
-69.7% YoY -58.6% QoQ
2023 60
-16.7% YoY 66.7% QoQ
0
-100.0% YoY -100.0% QoQ
68
-21.8% YoY inf% QoQ
34
-5.6% YoY -50.0% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Ruzurgi search interestLast update: February 08 2024 19:18:29.
Correlation coefficient between keyword and revenue is -0.42
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 19:18:30.

The average 5 years interest of Ruzurgi was 7.44 per week.
The last year interest of Ruzurgi compared to the last 5 years has changed by -58.06%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -70.57%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 19:18:35.

After 39 days of this quarter the interest is at 42.0. Based on that we can calculate that during remaining 52 days it will total up to 98.0.
Lambert-Eaton myasthenic syndrome expected interest is significantly higher compared to previous quarter (+164.9%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2019130
130
0.0% QoQ
151
16.2% QoQ
170
12.6% QoQ
2020 123
-5.4% YoY -27.6% QoQ
112
-13.8% YoY -8.9% QoQ
118
-21.9% YoY 5.4% QoQ
100
-41.2% YoY -15.3% QoQ
2021 74
-39.8% YoY -26.0% QoQ
65
-42.0% YoY -12.2% QoQ
137
16.1% YoY 110.8% QoQ
163
63.0% YoY 19.0% QoQ
2022 53
-28.4% YoY -67.5% QoQ
115
76.9% YoY 117.0% QoQ
98
-28.5% YoY -14.8% QoQ
13
-92.0% YoY -86.7% QoQ
2023 99
86.8% YoY 661.5% QoQ
166
44.3% YoY 67.7% QoQ
87
-11.2% YoY -47.6% QoQ
37
184.6% YoY -57.5% QoQ
2024 42
-57.6% YoY 13.5% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Lambert-Eaton myasthenic syndrome search interestLast update: February 08 2024 19:18:34.
Correlation coefficient between keyword and revenue is -0.08
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 19:18:35.

The average 5 years interest of Lambert-Eaton myasthenic syndrome was 8.36 per week.
The last year interest of Lambert-Eaton myasthenic syndrome compared to the last 5 years has changed by -14.83%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -37.76%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 05 2023 01:34:31.

After 34 days of this quarter the interest is at 85.0. Based on that we can calculate that during remaining 58 days it will total up to 230.0.
Myasthenia gravis expected interest is significantly higher compared to previous quarter (+59.7%) but similar to same quarter last year.

YearQ1Q2Q3Q4
2018 - - - 0
2019 290
inf% QoQ
62
-78.6% QoQ
183
195.2% QoQ
335
inf% YoY 83.1% QoQ
2020 321
10.7% YoY -4.2% QoQ
101
62.9% YoY -68.5% QoQ
173
-5.5% YoY 71.3% QoQ
65
-80.6% YoY -62.4% QoQ
2021 171
-46.7% YoY 163.1% QoQ
124
22.8% YoY -27.5% QoQ
179
3.5% YoY 44.4% QoQ
129
98.5% YoY -27.9% QoQ
2022 100
-41.5% YoY -22.5% QoQ
85
-31.5% YoY -15.0% QoQ
295
64.8% YoY 247.1% QoQ
335
159.7% YoY 13.6% QoQ
2023 184
84.0% YoY -45.1% QoQ
176
107.1% YoY -4.3% QoQ
144
-51.2% YoY -18.2% QoQ
85
-74.6% YoY -41.0% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Myasthenia gravis search interestLast update: November 05 2023 01:34:30.
Correlation coefficient between keyword and revenue is 0.03
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 01:34:31.

The average 5 years interest of Myasthenia gravis was 13.6 per week.
The last year interest of Myasthenia gravis compared to the last 5 years has changed by 4.34%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -10.47%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 19:18:42.

After 39 days of this quarter the interest is at 313.0. Based on that we can calculate that during remaining 52 days it will total up to 730.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019505
871
72.5% QoQ
786
-9.8% QoQ
775
-1.4% QoQ
2020 696
37.8% YoY -10.2% QoQ
578
-33.6% YoY -17.0% QoQ
643
-18.2% YoY 11.2% QoQ
694
-10.5% YoY 7.9% QoQ
2021 695
-0.1% YoY 0.1% QoQ
779
34.8% YoY 12.1% QoQ
663
3.1% YoY -14.9% QoQ
689
-0.7% YoY 3.9% QoQ
2022 778
11.9% YoY 12.9% QoQ
718
-7.8% YoY -7.7% QoQ
622
-6.2% YoY -13.4% QoQ
739
7.3% YoY 18.8% QoQ
2023 706
-9.3% YoY -4.5% QoQ
738
2.8% YoY 4.5% QoQ
702
12.9% YoY -4.9% QoQ
760
2.8% YoY 8.3% QoQ
2024 313
-55.7% YoY -58.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Spinal muscular atrophy search interestLast update: February 08 2024 19:18:42.
Correlation coefficient between keyword and revenue is 0.2
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 19:18:43.

The average 5 years interest of Spinal muscular atrophy was 55.36 per week.
The last year interest of Spinal muscular atrophy compared to the last 5 years has changed by 0.63%.
The interest for Spinal muscular atrophy is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by -9.75%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 05 2023 01:35:26.

After 34 days of this quarter the interest is at 57.0. Based on that we can calculate that during remaining 58 days it will total up to 154.0.
Catalyst Pharmaceuticals stock price expected interest is significantly higher compared to same quarter last year (+381.2%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 0
2019 0
0
0
0
2020 0
0
94
inf% YoY inf% QoQ
102
inf% YoY 8.5% QoQ
2021 176
inf% YoY 72.5% QoQ
237
inf% YoY 34.7% QoQ
114
21.3% YoY -51.9% QoQ
197
93.1% YoY 72.8% QoQ
2022 24
-86.4% YoY -87.8% QoQ
234
-1.3% YoY 875.0% QoQ
105
-7.9% YoY -55.1% QoQ
32
-83.8% YoY -69.5% QoQ
2023 161
570.8% YoY 403.1% QoQ
77
-67.1% YoY -52.2% QoQ
134
27.6% YoY 74.0% QoQ
57
78.1% YoY -57.5% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Catalyst Pharmaceuticals stock price search interestLast update: November 05 2023 01:35:26.
Correlation coefficient between keyword and revenue is 0.27
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 01:35:26.

The average 5 years interest of Catalyst Pharmaceuticals stock price was 6.71 per week.
The last year interest of Catalyst Pharmaceuticals stock price compared to the last 5 years has changed by 32.19%.
This is something to be checked.
This didn't exist 5 years ago.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Catalyst Pharmaceuticals careers to provide analysis

Correlation between past revenue and Catalyst Pharmaceuticals careers search interest

There is not enough data for Catalyst Pharmaceuticals careers to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Catalyst Pharmaceuticals careers to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: November 05 2023 01:35:40.

After 34 days of this quarter the interest is at 27.0. Based on that we can calculate that during remaining 58 days it will total up to 73.0.
Catalyst Pharmaceuticals news expected interest is significantly lower compared to same quarter last year (-53.5%) but similar to previous quarter.

YearQ1Q2Q3Q4
2018 - - - 231
2019 55
-76.2% QoQ
74
34.5% QoQ
63
-14.9% QoQ
38
-83.5% YoY -39.7% QoQ
2020 22
-60.0% YoY -42.1% QoQ
128
73.0% YoY 481.8% QoQ
187
196.8% YoY 46.1% QoQ
175
360.5% YoY -6.4% QoQ
2021 244
1009.1% YoY 39.4% QoQ
171
33.6% YoY -29.9% QoQ
37
-80.2% YoY -78.4% QoQ
109
-37.7% YoY 194.6% QoQ
2022 126
-48.4% YoY 15.6% QoQ
66
-61.4% YoY -47.6% QoQ
137
270.3% YoY 107.6% QoQ
157
44.0% YoY 14.6% QoQ
2023 123
-2.4% YoY -21.7% QoQ
95
43.9% YoY -22.8% QoQ
94
-31.4% YoY -1.1% QoQ
27
-82.8% YoY -71.3% QoQ
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Catalyst Pharmaceuticals news search interestLast update: November 05 2023 01:35:40.
Correlation coefficient between keyword and revenue is 0.08
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: November 05 2023 01:35:41.

The average 5 years interest of Catalyst Pharmaceuticals news was 9.07 per week.
The last year interest of Catalyst Pharmaceuticals news compared to the last 5 years has changed by -4.19%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by 6.89%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Catalyst Pharmaceuticals competitors to provide analysis

Correlation between past revenue and Catalyst Pharmaceuticals competitors search interest

There is not enough data for Catalyst Pharmaceuticals competitors to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Catalyst Pharmaceuticals competitors to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for CPRX
Earnings date: 2024-03-13 After close
Company name: Catalyst Pharmaceuticals Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T02:56:00-04:00

PR Newswire
Are CPRX, UNF, RMAX, ACR Obtaining Fair Deals for their Shareholders?

2026-05-11T20:12:45Z

GlobeNewswire
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results

2026-05-08T17:56:00-04:00

PR Newswire
Are CPRX, TBRG, MDV, ACR Obtaining Fair Deals for their Shareholders?

2026-05-08T19:10:38Z

Analyst Upgrades
Citigroup Downgrades Catalyst Pharmaceuticals to Neutral, Lowers Price Target to $31.5

2026-05-07T20:02:00Z

GlobeNewswire
Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast

2026-05-07T10:00:00-04:00

PR Newswire
Shareholder Alert: Ademi LLP investigates whether Catalyst Pharmaceuticals Inc. is obtaining a Fair Price for Public Shareholders

2026-05-07T13:40:01Z

Analyst Upgrades
Stephens & Co. Downgrades Catalyst Pharmaceuticals to Equal-Weight

2026-05-07T07:25:34Z

GlobeNewswire
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease

2026-05-07T06:44:12Z

GlobeNewswire
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Hetero Labs Ltd.

2026-05-07T06:24:26.447Z

Reuters
Italy's Angelini Pharma to buy Catalyst Pharmaceuticals for $4.1 billion

2026-04-28T12:03:00Z

GlobeNewswire
Catalyst Pharmaceuticals to Report First Quarter 2026 Financial Results on May 11, 2026

2026-03-06T13:03:00Z

GlobeNewswire
Catalyst Pharmaceuticals to Showcase Real‑World Findings in Duchenne Muscular Dystrophy and Host Vamorolone-Focused Symposium at the 2026 MDA Clinical & Scientific Conference

2026-03-03T18:00:47Z

Analyst Upgrades
Citigroup Maintains Buy on Catalyst Pharmaceuticals, Raises Price Target to $35

2026-02-25T21:07:55Z

GlobeNewswire
Catalyst Pharmaceuticals Reports Record Fourth Quarter and Record Full Year 2025 Financial Results and Provides 2026 Financial Guidance

2026-02-24T13:03:00Z

GlobeNewswire
Catalyst Pharmaceuticals to Participate in the Barclays 28th Annual Global Healthcare Conference